Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism - PubMed

Affiliations

• PMID: 17503474
• DOI: 10.1002/ajmg.b.30530

Case Reports

Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism

Christa Lese Martin et al. Am J Med Genet B Neuropsychiatr Genet. 2007.

Abstract

Cytogenetic imbalances are increasingly being realized as causes of autism. Here, we report a de novo translocation between the short arms of chromosomes 15 and 16 in a female with autism, epilepsy, and global developmental delay. FISH analysis identified a cryptic deletion of approximately 160 kb at the boundary of the first exon and first intron of the 1.7 Mb ataxin-2 binding protein-1 (A2BP1) gene, also called FOX1. Quantitative real time PCR (Q-PCR) analysis verified a deletion of exon 1 in the 5' promoter region of the A2BP1 gene. Reverse transcription PCR (qRT-PCR) showed reduced mRNA expression in the individual's lymphocytes, demonstrating the functional consequence of the deletion. A2BP1 codes for a brain-expressed RNA binding or splicing factor. Because of emerging evidence in the role of RNA processing and gene regulation in pervasive developmental disorders, we performed further screening of A2BP1 in additional individuals with autism from the Autism Genetics Resource Exchange (AGRE) collection. Twenty-seven SNPs were genotyped across A2BP1 in 206 parent-child trios and two regions showed association at P < or = 0.008 level. No additional deletions or clear mutations were identified in 88 probands by re-sequencing of all exons and surrounding intronic regions or quantitative PCR (Q-PCR) of exon 1. Although only nominal association was observed, and no obvious causal mutations were identified, these results suggest that A2BP1 may affect susceptibility or cause autism in a subset of patients. Further investigations in a larger sample may provide additional information regarding the involvement of this gene in the autistic phenotype.

Similar articles

• The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene.

  Bhalla K, Phillips HA, Crawford J, McKenzie OLD, Mulley JC, Eyre H, Gardner AE, Kremmidiotis G, Callen DF. Bhalla K, et al. J Hum Genet. 2004;49(6):308-311. doi: 10.1007/s10038-004-0145-4. Epub 2004 May 18. J Hum Genet. 2004. PMID: 15148587

• Rare inherited A2BP1 deletion in a proband with autism and developmental hemiparesis.

  Davis LK, Maltman N, Mosconi MW, Macmillan C, Schmitt L, Moore K, Francis SM, Jacob S, Sweeney JA, Cook EH. Davis LK, et al. Am J Med Genet A. 2012 Jul;158A(7):1654-61. doi: 10.1002/ajmg.a.35396. Epub 2012 Jun 7. Am J Med Genet A. 2012. PMID: 22678932 Free PMC article.

• The genetics of autism.

  Muhle R, Trentacoste SV, Rapin I. Muhle R, et al. Pediatrics. 2004 May;113(5):e472-86. doi: 10.1542/peds.113.5.e472. Pediatrics. 2004. PMID: 15121991 Review.

• A2BP1 gene polymorphisms association with olanzapine-induced weight gain.

  Dong L, Yan H, Huang X, Hu X, Yang Y, Ma C, Du B, Lu T, Jin C, Wang L, Yu H, Dong Z, Li W, Ruan Y, Zhang H, Zhang H, Mi W, Ma W, Li K, Lv L, Zhang D, Yue W. Dong L, et al. Pharmacol Res. 2015 Sep;99:155-61. doi: 10.1016/j.phrs.2015.06.003. Epub 2015 Jun 17. Pharmacol Res. 2015. PMID: 26092620

• Orchestration of neurodevelopmental programs by RBFOX1: implications for autism spectrum disorder.

  Bill BR, Lowe JK, Dybuncio CT, Fogel BL. Bill BR, et al. Int Rev Neurobiol. 2013;113:251-67. doi: 10.1016/B978-0-12-418700-9.00008-3. Int Rev Neurobiol. 2013. PMID: 24290388 Free PMC article. Review.

Cited by

• New genes for focal epilepsies with speech and language disorders.

  Turner SJ, Morgan AT, Perez ER, Scheffer IE. Turner SJ, et al. Curr Neurol Neurosci Rep. 2015 Jun;15(6):35. doi: 10.1007/s11910-015-0554-0. Curr Neurol Neurosci Rep. 2015. PMID: 25921602 Review.

• The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function.

  Gehman LT, Meera P, Stoilov P, Shiue L, O'Brien JE, Meisler MH, Ares M Jr, Otis TS, Black DL. Gehman LT, et al. Genes Dev. 2012 Mar 1;26(5):445-60. doi: 10.1101/gad.182477.111. Epub 2012 Feb 22. Genes Dev. 2012. PMID: 22357600 Free PMC article.

• Co-existence of other copy number variations with 22q11.2 deletion or duplication: a modifier for variable phenotypes of the syndrome?

  Li D, Tekin M, Buch M, Fan YS. Li D, et al. Mol Cytogenet. 2012 Apr 9;5(1):18. doi: 10.1186/1755-8166-5-18. Mol Cytogenet. 2012. PMID: 22487416 Free PMC article.

• Epigenetic factors and autism spectrum disorders.

  Flashner BM, Russo ME, Boileau JE, Leong DW, Gallicano GI. Flashner BM, et al. Neuromolecular Med. 2013 Jun;15(2):339-50. doi: 10.1007/s12017-013-8222-5. Epub 2013 Mar 7. Neuromolecular Med. 2013. PMID: 23468062 Review.

• Rbfox1 Mediates Cell-type-Specific Splicing in Cortical Interneurons.

  Wamsley B, Jaglin XH, Favuzzi E, Quattrocolo G, Nigro MJ, Yusuf N, Khodadadi-Jamayran A, Rudy B, Fishell G. Wamsley B, et al. Neuron. 2018 Nov 21;100(4):846-859.e7. doi: 10.1016/j.neuron.2018.09.026. Epub 2018 Oct 11. Neuron. 2018. PMID: 30318414 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal